insights_auto
Why is CUV down 2.88%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.42
arrow_downward
-2.88%(-0.22) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
78.79K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
78.79K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
TradingView
·
42 minutes ago
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
Benzinga
·
46 minutes ago
S&P 500 Rout Exposes Hidden Risk In 10% Buffered ETFs
The Motley Fool
·
4 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Traders Union
·
41 minutes ago
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com